News
The Trump administration on Tuesday said it plans to limit the approval of updated COVID-19 vaccines to adults over 65 and people who are high risk for severe infections, raising questions about ...
The Food and Drug Administration (FDA) says it’s only prioritizing covid vaccine approvals for adults older than 65 and others over the age of 6 months who have at least one “risk factor ...
In a paper published in the New England Journal of Medicine, FDA Commissioner Dr. Marty Makary ... Earlier this month, Health and Human Services Secretary Robert F. Kennedy Jr. mandated that ...
Companies focused on psychedelic medicines traded higher for the second straight session on Tuesday after FDA Commissioner Marty Makary said evaluating the potential of psilocybin, MDMA ...
HEALTH. ED TO YOU. LET’S PICK IT UP RIGHT THERE. MARIA. HERE TO DISCUSS SOME MORE. IS DOCTOR TODD AND FAMILIAR FACE HERE AT 430 ON NEWSCENTER 5. CHIEF OF INFECTIOUS DISEASES AT SOUTH SHORE HEALTH.
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain approvals. FDA Commissioner Marty Makary, M.D., and Center for Biologics ...
Under the control of anti-vaccine advocate Robert F. Kennedy Jr., the Food and ... written by Trump administration FDA Commissioner Martin Makary and the agency's new top vaccine regulator ...
This clearance is the second successful expanded FDA indication for IB-Stim, following its initial approval for Functional Abdominal Pain associated with Irritable Bowel Syndrome (IBS).
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Novavax ...
Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic whose department oversees the FDA, has been remaking the U.S. health system to align with President Donald Trump's goal of ...
FDA officials have outlined their new approach to COVID-19 vaccine approvals, allowing immunogenicity endpoints for high-risk groups, while calling for randomized controlled trials for those at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results